AAB Molecular Diagnostics Practice Test

The increased risk for myocardial infarction in heterozygous C282Y carriers is indeed understood to be a 2-fold increase. This association arises from the broader context of how iron overload, which is more pronounced in individuals with genetic predispositions such as C282Y mutations related to hereditary hemochromatosis, can impact cardiovascular health.

Heterozygous C282Y carriers typically have elevated iron levels compared to non-carriers, which can lead to an increased oxidative stress and inflammation. These factors contribute to vascular damage and are known risk factors for myocardial infarctions. Studies indicate that individuals with this genotype may experience this heightened risk, making the 2-fold increase a significant statistic in clinical discussions.

While the other options suggest lower or no increases, they do not reflect the current understanding of the relationship between genetic predisposition to iron overload and cardiovascular events. The evidence points towards a discernible, albeit modulated, risk in heterozygous carriers, emphasizing the importance of genetic screening and management for individuals at risk.